Clinical Trial Details

NODE 301

NODE 301: Multi-Centre, Randomized, Double-Blind, Placebo-Controlled, Efficacy, and Safety Study of Etripamil Nasal Spray for the Termination of Spontaneous Episodes of Paroxysmal Supraventricular Tachycardia

Purpose/Objective

Request Additional Trial Information
Full Trial Details: ClinicalTrials.gov

Condition: Paroxysmal supraventricular tachycardia (PSVT)
Study Type: Interventional
Phase: Phase III
Study Start Date: 06/18/2018
Study Completion Date: 07/2020

This trial aims to evaluate the efficacy and safety of etripamil NS 70 mg self-administered by patients who experience an episode of PSVT in an outpatient setting.

NCT Number

NCT03464019

Principal Investigator(s)

Sean Beinart, MD

Sponsor(s)

Milestone Pharmaceuticals

Participant Eligibility

• Age: 18 years and older
• Gender: Male, Female